1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with apyrase in 11 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (apyrase) | Trials (apyrase) | Recent Studies (post-2010) (apyrase) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,997 | 16 | 833 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessandri, C; Balsano, F; Cordova, C; Ghiselli, A; Iuliano, L; Pratico, D; Violi, F | 1 |
| Petty, AC; Scrutton, MC | 1 |
| Altman, R; Scazziota, A | 1 |
| Broekman, MJ; Kaplan, KL; Marcus, AJ; Safier, LB; Ullman, HL; Weksler, BB; Wong, KT | 1 |
| High, JA; Namm, DH | 1 |
| Rezaul, K; Sada, K; Taniguchi, T; Yamamura, H; Yanagi, S | 1 |
| Evans, RJ; Jarvis, GE | 1 |
| Evans, RJ; Heath, MF; Jarvis, GE | 1 |
| Guo, ZG; Yi, FX | 1 |
| Sachais, BS | 1 |
| Cattaneo, M; Lecchi, A; Lussana, F; Zighetti, ML | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and apyrase
| Article | Year |
|---|---|
Platelet-endothelial interactions in atherosclerosis.
Topics: Antigens, CD; Apyrase; Arteriosclerosis; Blood Platelets; Carrier Proteins; Cell Adhesion; Cell Adhesion Molecules; Cell Communication; Endothelium, Vascular; Epoprostenol; Humans; Hypolipidemic Agents; Nitric Oxide; Nitric Oxide Synthase; P-Selectin; Platelet Activating Factor; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Ubiquitin-Protein Ligases | 2001 |
10 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and apyrase
| Article | Year |
|---|---|
Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration.
Topics: alpha-Tocopherol; Apyrase; Aspirin; Blood Platelets; Collagen; Epinephrine; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Thromboxane A2; Tocopherols; Vitamin E | 1990 |
Platelet aggregation in whole blood: is the response to adrenaline, 5-hydroxytryptamine and PAF a direct consequence of stimulation by these agonists?
Topics: Apyrase; Azepines; Cell Count; Dioxanes; Dose-Response Relationship, Drug; Epinephrine; Hirudins; Humans; Idazoxan; Indomethacin; Ketanserin; Platelet Activating Factor; Platelet Aggregation; Serotonin; Triazines; Triazoles | 1989 |
Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Adenosine; Administration, Oral; Adult; Apyrase; Arachidonic Acids; Aspirin; Catechols; Drug Synergism; Epoprostenol; Humans; Indomethacin; Masoprocol; Platelet Activating Factor; Platelet Aggregation; Pyrazoles; Thromboxane B2; Time Factors; Umbelliferones | 1986 |
Effects of acetyl glyceryl ether phosphorylcholine on human platelet function in vitro.
Topics: Adenosine Diphosphate; Apyrase; beta-Thromboglobulin; Blood Platelets; Calcium; Creatine Kinase; Drug Synergism; Humans; Lysophosphatidylcholines; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Serotonin; Thromboxane A2 | 1981 |
Thrombin-induced formation of a polar lipid material within platelets that possesses platelet-activating activity.
Topics: Adenosine Diphosphate; Animals; Apyrase; Arachidonic Acids; Blood Platelets; Cattle; Indomethacin; Lipids; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thrombin | 1980 |
Protein-tyrosine kinase p72syk is activated by platelet activating factor in platelets.
Topics: Animals; Apyrase; Aspirin; Blood Platelets; Calcium; Enzyme Activation; Enzyme Precursors; Intracellular Signaling Peptides and Proteins; Phospholipid Ethers; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction; Stimulation, Chemical; Swine; Syk Kinase | 1994 |
Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro.
Topics: Animals; Apyrase; Aspirin; Dose-Response Relationship, Drug; Endotoxins; Heparin; Horses; In Vitro Techniques; Limulus Test; Microscopy; Microscopy, Electron; Nephelometry and Turbidimetry; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation | 1994 |
The role of ADP in endotoxin-induced equine platelet activation.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Apyrase; Blood Platelets; Endotoxins; Female; Horses; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Spectrophotometry | 1996 |
Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium.
Topics: Adenosine Diphosphate; Animals; Apyrase; Blood Platelets; Calcium; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1998 |
Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count.
Topics: Adenosine Diphosphate; Apyrase; Artifacts; Buffers; Centrifugation; Collagen; Humans; Nephelometry and Turbidimetry; Plasma; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Platelet Function Tests; Platelet-Rich Plasma | 2007 |